171 results on '"Yazbeck, Roger"'
Search Results
2. A cross-sectional study of associations between the 13C-sucrose breath test, the lactulose rhamnose assay, and growth in children at high risk of environmental enteropathy
3. Mechanistic inference of the metabolic rates underlying 13C breath test curves
4. Improving cost-effectiveness of endoscopic surveillance for Barrett’s esophagus by reducing low-value care: a review of economic evaluations
5. A review of breath analysis techniques in head and neck cancer
6. Circulating Dipeptidyl Peptidase Activity Is a Potential Biomarker for Inflammatory Bowel Disease
7. Development of a non-invasive exhaled breath test for the diagnosis of head and neck cancer
8. Prebiotics Fructo-, Galacto-, and Mannan-Oligosaccharide Do Not Protect against 5-Fluorouracil–Induced Intestinal Mucositis in Rats
9. Breath methane to hydrogen ratio as a surrogate marker of intestinal dysbiosis in head and neck cancer
10. Development of a 13C Stable Isotope Assay for Dipeptidyl Peptidase-4 Enzyme Activity A New Breath Test for Dipeptidyl Peptidase Activity
11. Mechanistic inference of the metabolic rates underlying $$^{13}$$C breath test curves
12. Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein
13. The medical research future fund: A good deal for health?
14. The nedical research future fund: A good deal for health?
15. Dipeptidyl Peptidases and Inflammatory Bowel Disease
16. Mechanistic inference of the metabolic rates underlying 13C breath test curves
17. Growth factor based therapies and intestinal disease: Is glucagon-like peptide-2 the new way forward?
18. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
19. Emerging evidence on the pathobiology of mucositis
20. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients
21. Breath 13CO2—evidence for a noninvasive biomarker to measure added refined sugar uptake
22. Optimisation, validation and field applicability of a 13C-sucrose breath test to assess intestinal function in environmental enteropathy among children in resource poor settings: study protocol for a prospective study in Bangladesh, India, Kenya, Jamaica, Peru and Zambia
23. The Effect of Isoleucine Supplementation on Body Weight Gain and Blood Glucose Response in Lean and Obese Mice
24. Effects of the new probiotic streptococcus thermophilus TH-4, and its derivatives, on severity of mucositis induced by 5-fluorouracil in rats
25. Dipeptidyl peptidase-iv inhibition enhances recovery from experimental colitis in mice: 44
26. The Use of Selected Ion Flow Tube-Mass Spectrometry Technology to Identify Breath Volatile Organic Compounds for the Detection of Head and Neck Squamous Cell Carcinoma: A Pilot Study
27. Breath 13CO2—evidence for a noninvasive biomarker to measure added refined sugar uptake.
28. In vitrodevelopment and validation of a non-invasive13C-stable isotope assay for ornithine decarboxylase
29. From blood to breath: New horizons for esophageal cancer biomarkers
30. Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein.
31. Combined Effects of Muricid Extract and 5-Fluorouracil on Intestinal Toxicity in Rats
32. Indigenous Health: ACTION on Prevention - 50th Annual Australian Society for Medical Research National Scientific Conference (Conference report)
33. Dipeptidyl peptidase expression during experimental colitis in mice
34. Effects ofStreptococcus thermophilusTH-4 in a rat model of doxorubicin-induced mucositis
35. Indigenous Health: ACTION on Prevention - 50th Annual Australian Society for Medical Research National Scientific Conference
36. Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis
37. Non-invasive detection of a palifermin-mediated adaptive response following chemotherapy-induced damage to the distal small intestine of rats
38. Dipeptidyl peptidase expression during experimental colitis in mice
39. M1838 Dipeptidyl Peptidase-IV Inhibitors and Small Intestinal Adaptation During Experimental Colitis
40. Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis
41. Complementary medicines: Emerging therapies for intestinal mucositis
42. The herbal extract Iberogast® improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositis
43. Gastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIA
44. W1686 The Effects of Orally-Administered Emu Oil in a Rat Model of Chemotherapy-Induced Mucositis
45. Effects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent, 5-Fluorouracil (5-FU)
46. Grape seed extract protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis.
47. Lactobacillus fermentumBR11 and Fructo-Oligosaccharide Partially Reduce Jejunal Inflammation in a Model of Intestinal Mucositis in Rats
48. T1321 An Extract from Grape Seed Protects IEC-6 Cells from Chemotherapy-Induced Cytotoxicity and Improves Parameters of Small Intestinal Mucositis in Rats with Experimentally-Induced Mucositis
49. T1320 The Herbal Extract, Iberogast, Partially Improves Small Intestinal Integrity in Rats with Mucositis Induced By 5-Fluorouracil
50. T1297 Dextran Sulphate Sodium Induced Colitis in Mice Induces Jejunal and Ileal Changes in Villus Height and Crypt Depth Potentially Regulated By Dipeptidyl Peptidase Activity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.